Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 2
2011 1
2012 4
2013 2
2015 2
2017 1
2020 2
2021 5
2022 5
2023 4
2024 10
2025 8
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.
Chiva L, Zanagnolo V, Querleu D, Martin-Calvo N, Arévalo-Serrano J, Căpîlna ME, Fagotti A, Kucukmetin A, Mom C, Chakalova G, Aliyev S, Malzoni M, Narducci F, Arencibia O, Raspagliesi F, Toptas T, Cibula D, Kaidarova D, Meydanli MM, Tavares M, Golub D, Perrone AM, Poka R, Tsolakidis D, Vujić G, Jedryka MA, Zusterzeel PLM, Beltman JJ, Goffin F, Haidopoulos D, Haller H, Jach R, Yezhova I, Berlev I, Bernardino M, Bharathan R, Lanner M, Maenpaa MM, Sukhin V, Feron JG, Fruscio R, Kukk K, Ponce J, Minguez JA, Vázquez-Vicente D, Castellanos T, Chacon E, Alcazar JL; SUCCOR study Group. Chiva L, et al. Among authors: arencibia o. Int J Gynecol Cancer. 2020 Sep;30(9):1269-1277. doi: 10.1136/ijgc-2020-001506. Epub 2020 Aug 11. Int J Gynecol Cancer. 2020. PMID: 32788262 Free article.
Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial.
Cibula D, Marnitz S, Jarkovský J, Kocián R, Dundr P, Klát J, Zapardiel I, Arencibia O, Landoni F, Presl J, Raspagliesi F, Zikán M, van Lonkhuijzen LR, Torne A, Sláma J, Minar L, Ostojich M, Pilka R, Petiz AF, Petzel A, Burgetová A, Fischerová D, Nemejcova K, Köhler C. Cibula D, et al. Among authors: arencibia o. Nat Cancer. 2025 Sep;6(9):1585-1594. doi: 10.1038/s43018-025-01016-y. Epub 2025 Jul 4. Nat Cancer. 2025. PMID: 40615729 Clinical Trial.
SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer.
Chiva L, Ordas P, Mishra J, Ayhan A, Lee YY, Bogani G, Sp S, Lomnytska M, Stukan M, Fruscio R, Chura BF, Salcedo-Hernandez RA, De Iaco P, Haidopoulos D, Svintsitskiy V, Jain V, Stanciu P, Rawert FL, Akdemir C, Abdallah R, Chacon E, Minguez JA, Gil-Moreno A, Kharchenko K, Mofrad MH, Gebauer G, Díaz-Feijoo B, Scibilia G, Klaric M, Škof E, Saadeh FA, Mueller MD, Saarelainen S, Tejerizo García Á, Fotopoulou C, Coronado P, Dermikiran F, Goffin F, Tsolakidis D, Gonzalez-Martin A; SUROVA Study Group. Chiva L, et al. Int J Gynecol Cancer. 2025 Dec;35(12):102688. doi: 10.1016/j.ijgc.2025.102688. Int J Gynecol Cancer. 2025. PMID: 41352872 Free article.
46 results